These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17434108)

  • 61. Effect of ultrasound probe on dose delivery during real-time ultrasound-guided tumor tracking.
    Wu J; Dandekar O; Nazareth D; Lei P; D'Souza W; Shekhar R
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():3799-802. PubMed ID: 17946582
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Transrectal ultrasound in prostate cancer patients: what can we really see?].
    Boehm K; Beyer B; Schneidewind L; Borgmann H
    Urologe A; 2013 Dec; 52(12):1712-4. PubMed ID: 24253520
    [No Abstract]   [Full Text] [Related]  

  • 63. The Use of Ultrasound Imaging in the External Beam Radiotherapy Workflow of Prostate Cancer Patients.
    Camps SM; Fontanarosa D; de With PHN; Verhaegen F; Vanneste BGL
    Biomed Res Int; 2018; 2018():7569590. PubMed ID: 29619375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.
    Zapotoczna A; Sasso G; Simpson J; Roach M
    Neoplasia; 2007 Jun; 9(6):455-63. PubMed ID: 17603627
    [TBL] [Abstract][Full Text] [Related]  

  • 65. State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma.
    Bermudez RS; Izaguirre A; Roach M
    Future Oncol; 2007 Feb; 3(1):103-11. PubMed ID: 17280507
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancer.
    Feleppa EJ; Ennis RD; Schiff PB; Wuu CS; Kalisz A; Ketterling J; Urban S; Liu T; Fair WR; Porter CR; Gillespie JR
    Brachytherapy; 2002; 1(1):48-53. PubMed ID: 15062187
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Counterpoint: Is there a need for supplemental XRT in intermediate-risk prostate cancer patients?
    Stone NN
    Brachytherapy; 2013; 12(5):393-7. PubMed ID: 23958340
    [No Abstract]   [Full Text] [Related]  

  • 68. Prostate cancer treatment with radioactive seed implantation.
    Davis DL
    AORN J; 1998 Jul; 68(1):18, 21-3, 26-30 passim; quiz 42, 45. PubMed ID: 9675408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypofractionation in prostate cancer: how far can we go?
    Hoskin PJ
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):727-8. PubMed ID: 18848440
    [No Abstract]   [Full Text] [Related]  

  • 70. Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients.
    Spratt DE; Zelefsky MJ
    Brachytherapy; 2013; 12(5):389-92. PubMed ID: 23988506
    [No Abstract]   [Full Text] [Related]  

  • 71. Re: Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.
    Taneja SS
    J Urol; 2014 Apr; 191(4):983-5. PubMed ID: 24703117
    [No Abstract]   [Full Text] [Related]  

  • 72. [Failure patterns following external beam radiotherapy with or without additional focal boost in the randomized FLAME trial for localized prostate cancer].
    Spohn SKB; Grosu AL
    Strahlenther Onkol; 2022 Sep; 198(9):869-872. PubMed ID: 35579679
    [No Abstract]   [Full Text] [Related]  

  • 73. Applications of prostate ultrasonography.
    Waterhouse RL; Resnick MI
    Urology; 1990 Nov; 36(5 Suppl):18-24. PubMed ID: 2238312
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Point/Counterpoint. Intensity modulated electronic brachytherapy will soon become the brachytherapy treatment of choice for irregularly shaped tumor cavities or those closely bounded by critical structures.
    Sternick ES; Todor DA; Orton CG
    Med Phys; 2009 Mar; 36(3):681-3. PubMed ID: 19378728
    [No Abstract]   [Full Text] [Related]  

  • 75. Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: a proposed standard for the conduct of therapy.
    Rajpal SL; Campbell IM; Collins GN; O'Reilly PH; Brown SC
    BJU Int; 2007 Apr; 99(4):942-3. PubMed ID: 17378856
    [No Abstract]   [Full Text] [Related]  

  • 76. Letter to the editor.
    Gossman MS; Pahikkala AJ; Rising MB; McGinley PH
    J Appl Clin Med Phys; 2010 Dec; 12(1):242-243. PubMed ID: 21330993
    [No Abstract]   [Full Text] [Related]  

  • 77. [Dose escalation in prostate cancer-standard dose versus dose escalation with simultaneous integrated boost to intraprostatic tumor formation: results from the FLAME Trial].
    Klautke G
    Strahlenther Onkol; 2022 Feb; 198(2):212-213. PubMed ID: 35037083
    [No Abstract]   [Full Text] [Related]  

  • 78. Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer?
    Brenner MJ; Kaplan ID
    J Clin Oncol; 2014 Jun; 32(17):1851-2. PubMed ID: 24778396
    [No Abstract]   [Full Text] [Related]  

  • 79. Advances in radiation therapy.
    Forstner DF; Yap ML
    Med J Aust; 2015 Nov; 203(10):394-5. PubMed ID: 26561898
    [No Abstract]   [Full Text] [Related]  

  • 80. Brachytherapy for prostate cancer.
    Wirth MP; Hakenberg OW
    Urol Int; 1999; 63(2):87-91. PubMed ID: 10592495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.